Avelumab - Latest Advances

Avelumab real-world use in advanced Merkel cell carcinoma: a systematic review and non-comparative meta-analysis.

Journal: Future oncology (London, England)

Published: January 23, 2026

Current Landscape of Sequential Treatment Strategy in Metastatic Urothelial Carcinoma

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 19, 2026

Regarding "Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Receiving Avelumab and Subsequent Flare-up".

Journal: Journal of investigational allergology & clinical immunology

Published: January 14, 2026

Checkpoint Inhibitors and Beyond: A Systematic Review of Immunotherapy in Cutaneous Malignancies.

Journal: Cureus

Published: December 11, 2025

Regarding "Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Receiving Avelumab and Subsequent Flare-up".

Journal: Journal of investigational allergology & clinical immunology

Published: December 03, 2025

Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004).

Journal: World journal of urology

Published: November 26, 2025

Evaluating Treatment Effects with Patient-Response-Related Outcomes in Comparative Clinical Trials.

Journal: NEJM evidence

Published: November 25, 2025

Dynamic PD-L1 Regulation Shapes Tumor Immune Escape and Response to Immunotherapy.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Avelumab Treatment in Very Elderly People With Advanced Merkel Cell Carcinoma: A Case Report and Review of the Literature.

Journal: Cureus

Published: November 24, 2025

Drug safety concern of Avelumab: real world data analysis in FAERS database.

Journal: The American journal of the medical sciences

Published: November 07, 2025

Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological Consortium.

Journal: Japanese journal of clinical oncology

Published: November 06, 2025

Immune Checkpoint Inhibitor-Induced Miller Fisher Syndrome: A Case of Relapsing Symptoms Requiring a Slow Corticosteroid Taper.

Journal: Cureus

Published: November 06, 2025

Filters

Avelumab real-world use in advanced Merkel cell carcinoma: a systematic review and non-comparative meta-analysis.

Avelumab real-world use in advanced Merkel cell carcinoma: a systematic review and non-comparative meta-analysis.

Current Landscape of Sequential Treatment Strategy in Metastatic Urothelial Carcinoma

Current Landscape of Sequential Treatment Strategy in Metastatic Urothelial Carcinoma

Regarding "Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Receiving Avelumab and Subsequent Flare-up".

Regarding "Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Receiving Avelumab and Subsequent Flare-up".

Checkpoint Inhibitors and Beyond: A Systematic Review of Immunotherapy in Cutaneous Malignancies.

Checkpoint Inhibitors and Beyond: A Systematic Review of Immunotherapy in Cutaneous Malignancies.

Regarding "Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Receiving Avelumab and Subsequent Flare-up".

Regarding "Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Induced by Meropenem in a Patient Receiving Avelumab and Subsequent Flare-up".

Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004).

Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004).

Evaluating Treatment Effects with Patient-Response-Related Outcomes in Comparative Clinical Trials.

Evaluating Treatment Effects with Patient-Response-Related Outcomes in Comparative Clinical Trials.

Dynamic PD-L1 Regulation Shapes Tumor Immune Escape and Response to Immunotherapy.

Dynamic PD-L1 Regulation Shapes Tumor Immune Escape and Response to Immunotherapy.

Avelumab Treatment in Very Elderly People With Advanced Merkel Cell Carcinoma: A Case Report and Review of the Literature.

Avelumab Treatment in Very Elderly People With Advanced Merkel Cell Carcinoma: A Case Report and Review of the Literature.

Drug safety concern of Avelumab: real world data analysis in FAERS database.

Drug safety concern of Avelumab: real world data analysis in FAERS database.

Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological Consortium.

Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological Consortium.

Immune Checkpoint Inhibitor-Induced Miller Fisher Syndrome: A Case of Relapsing Symptoms Requiring a Slow Corticosteroid Taper.

Immune Checkpoint Inhibitor-Induced Miller Fisher Syndrome: A Case of Relapsing Symptoms Requiring a Slow Corticosteroid Taper.